Syros Pharmaceuticals (SYRS)

• Market cap: $5.44M
• 1 day: -0.49%
• 5 days: -0.98%
• 1 month: -21.11%
• 3 months: -89.49%
• 6 months: -96.51%
• Year to date: -97.41%
• 1 year: -97.10%
• 5 years: -99.72%
• 10 years: -99.89%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.

Employees: 68

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

4.31% less ownership

Funds ownership: 76.29% [Q2] → 71.98% (-4.31%) [Q3]

9% less funds holding

Funds holding: 70 [Q2] → 64 (-6) [Q3]

33% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 18

33% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 15

50% less funds holding in top 10

Funds holding in top 10: 2 [Q2] → 1 (-1) [Q3]

61% less capital invested

Capital invested by funds: $105M [Q2] → $41.3M (-$63.9M) [Q3]

90% less call options, than puts

Call options by funds: $281K | Put options by funds: $2.73M

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $1 393% upside
• Avg. target: $1 393% upside
• High target: $1 393% upside

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

HC Wainwright & Co. Andrew Fein 31% 1-year accuracy 102 / 328 met price target

393% upside $1

Neutral Downgraded

13 Nov 2024